CClaimWatch
Claims closedsecurities

Novo Nordisk Securities Litigation Settlement

This settlement is closed to new claims. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →

What happened

Novo Nordisk and three individual defendants allegedly violated federal securities laws by making false and misleading statements concerning Novo Nordisk's business and financial results during the class period. The defendants deny all allegations and maintain they have valid defenses.

Do you qualify?

Anyone who purchased American Depositary Receipts of Novo Nordisk A/S between February 3, 2015 and February 2, 2017, inclusive, and was damaged thereby. Excluded are Novo Nordisk, its directors and officers, subsidiaries, and those who requested exclusion.

How to file

The claims administration is now complete as of June 2023. Distributions of the settlement fund have already occurred on June 3, 2024 and July 28, 2025, with subsequent distributions on a rolling basis. To check claim status or obtain information, contact the Claims Administrator at 1-833-674-0167 or info@NovoNordiskSecuritiesLitigation.com.

This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.

More securities settlements

View all →